Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Retinopathy · Retinal Vein Occlusion · Diabetic Retinopathy · Macular Degeneration
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Julie M Rosenthal, MD)
Study leads
Richard B Dorshow, PhD
Study Director
MediBeacon